Steven Pergam, MD, MPH
banner
pergamic.bsky.social
Steven Pergam, MD, MPH
@pergamic.bsky.social
Transplant ID Doc and IP Director @Fred Hutchinson Cancer Center/ Faculty @UWMedicine. #InfectionPrevention #TxID #vaccines #prevention #protection #medtwitter

Posts/comments are my own and not reflective of my institutions.
Bravo!
October 31, 2025 at 3:50 PM
Reposted by Steven Pergam, MD, MPH
Important Ongoing Studies where we have or will have publications soon:

Pritelivir for refractory or resistant HSV (presented @idweek.bsky.social by @kottonnelson.bsky.social): www.aicuris.com/press-releas...

CD388 for prevention of influenza: www.cidara.com/news/cidara-...
Aicuris Announces Pritelivir Met Primary Endpoint in Immunocompromised Herpes Simplex Virus-infected Patients in Phase 3 Pivotal Trial - Aicuris
Aicuris today announced that the Phase 3 trial of its lead candidate pritelivir has met its primary and secondary endpoint. The aim of the trail was to evaluate
www.aicuris.com
October 22, 2025 at 1:40 PM
Reposted by Steven Pergam, MD, MPH
The entire HR department at the CDC is gone. Everyone at the IRB, which makes sure studies are conducted ethically and rigorously, and the ethics office, which oversee conflicts of interest for CDC leaders and advisory committee members, were also let go.
www.theguardian.com/us-news/2025...
‘Instability and confusion’ as CDC slashes 1,300 jobs before reinstating half
Trump administration says 700 notices were sent in error, while top CDC officer says ‘they didn’t think through what they were doing’
www.theguardian.com
October 14, 2025 at 3:13 PM
Reposted by Steven Pergam, MD, MPH
👉 10/20/25: 5-5:25pm TID fellows, Drs. Gabriel Motoa Cardona (Columbia Presbyterian-Cornell) and Stella Radosta (UT Southwestern) will each present a case, with discussions led by Drs. Alan Koff (UC Davis) and Alpana Waghmare (University of Washington/Fred Hutch)
October 10, 2025 at 2:41 PM
Just awful
October 3, 2025 at 5:05 AM